|
|
|
|
Antivirals used for treatment of Respiratory viruses There are a number of viruses that cause respiratory tract infections. The majority of infections do not require treatments. Some of the infection can result in severe illnesses in some group of patients, for instance in preterm babies or immunocompromised patients. In the elderly population, infections with influenza is known to cause high fatalities. Antivirals is believed to reduce the severity of illness, and shorten the duration of illness. It can also prevent loss of life.
Influenza A Oseltamivir For treatment-75mg twice daily for 5 days For prevention- 75mg once daily for at least 7 days
Zanamivir For treatment- 10 mg twice daily for 5 days Not licensed for prophylaxis.
Amantadine For treatment- 100 mg daily for 5 days For prevention- 100 mg daily for up to 6 weeks
The use of antiviral drugs is recommended for Ø Elderly patients presented within 48 hours of infections. Ø Immunocompromised patients Ø Patients with severe illness
Prophylaxis is only given to patients that have risk factor to develop severe infections if they have not been vaccinated for influenza strains that circulate at that particular season. Vaccination should be offered with antivirals as prophylaxis.
Influenza B Oseltamivir For treatment-75mg twice daily for 5 days For prevention- 75mg once daily for at least 7 days
Zanamivir For treatment- 10 mg twice daily for 5 days It is not licensed for prophylaxis.
Treatment with antivirals is recommended for Ø Elderly patients who present within 48 hours of infections. Ø Immunocompromised patients Ø Patients with severe illness
Non- Flu ( RSV, Parainfluenza, Adenovirus) Ribavirin Inhalation or nebulisation. 20mg/ml solution for 12 to 18 hours for 3 to 5days
The indications to treat patients include Ø moderate to severe bronchiolitis Ø If the patient is immunocompromised. Ø Severe infection with RSV, Parainfluenza or Adenoviruses
For Adenovirus Cidofovir or Ribavirin can be used. Indications
SARS There is no effective antiviral; however, there is only one anecdotal report that showed retrospectively that some patients on a protease inhibitor for HIV infections were benefited. As there is no any antiviral considered to be effective, it is not unreasonable to advise Lopinavir to treat patients infected with SARS. Lopinavir Dose
v 400mg with 100mg of ritonavir twice daily
Ribavirin Given by inhalation or nebulisation 20mg/ml solution for 12 to 18 hours for 3 to 5days
NB: There is no proper clinical trial however the above two drugs may have potential benefit.
|
|
Date this page is updated: 04/03/2007 23:13:30 www. virologynotebook.co.uk
|